Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.10. | Celldex Therapeutics, Inc.: Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria | 67 | GlobeNewswire (Europe) | First to demonstrate clinical benefit in patients with chronic inducible urticaria (CIndU) in large, randomized, placebo-controlled study Favorable safety and tolerability Plan to advance CIndU into... ► Artikel lesen | |
26.10. | Travere Therapeutics, Inc.: Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024 | 37 | GlobeNewswire (Europe) | Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS Study, PROTECT open-label extension, and real-world evidence... ► Artikel lesen | |
26.10. | Andretti Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 28, 2024 | 275 | GlobeNewswire (Europe) | New York, NY, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Andretti Acquisition Corp. II (Nasdaq: POLEU) (the "Company") announced today that, commencing October 28, 2024, holders of the units sold in the Company's... ► Artikel lesen | |
26.10. | BlueOne Card Inc., Announces Definitive Agreement to Acquire Millennium EBS, Inc. in a $12 Million Deal | 685 | GlobeNewswire (Europe) | LOS ANGELES, Oct. 25, 2024 (GLOBE NEWSWIRE) -- BlueOne Card, Inc. (OTCQX: BCRD) ("BlueOne Card," the "Company"), a leading fintech provider of payment hub solutions and prepaid debit cards, today... ► Artikel lesen | |
26.10. | SIMPPLE LTD. Announces Receipt of Nasdaq Staff Determination Letter | 981 | GlobeNewswire (Europe) | Singapore, Oct. 25, 2024 (GLOBE NEWSWIRE) -- SIMPPLE LTD. (Nasdaq: SPPL) (the "Company" or "SIMPPLE"), an advanced technology solution provider in the emerging property-technology ("PropTech") space... ► Artikel lesen | |
26.10. | Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 | 1.049 | GlobeNewswire (Europe) | Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
Selected for late-breaking oral presentation at ASN kidney week, the... ► Artikel lesen | |
26.10. | The Organizing Committee of the Summit on BDS Applications: The Third International Summit on BDS Applications Kicked Off in Zhuzhou | 505 | GlobeNewswire (Europe) | ZHUZHOU, China, Oct. 26, 2024 (GLOBE NEWSWIRE) -- The 3rd International Summit on BDS (Beidou Navigation Satellite System) Applications was held in Zhuzhou from October 24th-25th. With the theme of... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.917 |
EVOTEC | 2.169 |
TUI | 1.844 |
BAYER | 1.791 |
NVIDIA | 1.676 |
NEL | 1.279 |
RENK GROUP | 1.140 |
RHEINMETALL | 1.042 |
TESLA | 879 |
PALANTIR TECHNOLOGIES | 829 |
DEUTSCHE BANK | 773 |
VOLKSWAGEN | 750 |
MICROSTRATEGY | 717 |
BYD | 697 |
PLUG POWER | 663 |
COMMERZBANK | 656 |
BASF | 633 |
JINKOSOLAR | 616 |
MERCEDES-BENZ | 593 |
AMAZON | 577 |
DEUTSCHE TELEKOM | 554 |
INTEL | 553 |
BMW | 545 |
ALLIANZ | 539 |
THYSSENKRUPP | 534 |